Loading clinical trials...
Loading clinical trials...
To Evaluate the Efficacy and Safety of Combination Therapy of Pitavastatin and Ezetimibe Versus Monotherapy of Pitavastatin in Patients With Primary Hypercholesterolemia.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
JW Pharmaceutical
NCT06314919 · Primary Hypercholesterolemia, Mixed Dyslipidemia
NCT06568471 · Hypercholesterolemia, Dyslipidemias, and more
NCT05399992 · Primary Hypercholesterolemia, Mixed Dyslipidemia
NCT07441317 · Primary Hypercholesterolemia or Mixed Hyperlipidemia
NCT07444086 · Primary Hypercholesterolemia or Mixed Hyperlipidemia
Gangdong Sacred Heart Hospital
Seoul, Korea
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions